Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes Treated with Insulin”

491 trials

Showing 20 of 491 results

Testing effectiveness (Phase 2)Study completedNCT04437485
What this trial is testing

EIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes Risk

Who this might be right for
DepressionMajor Depressive DisorderDysthymic Disorder+4 more
Indiana University 46
Not applicableLooking for participantsNCT06081387
What this trial is testing

The Effect of Aerobic and Resistance Training in Patients With Type 2 Diabetes on Vitamin D Treatment

Who this might be right for
Diabetes Mellitus, Type 2
University Ramon Llull 80
Large-scale testing (Phase 3)Study completedNCT01076647
What this trial is testing

Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 467
Large-scale testing (Phase 3)Study completedNCT00600626
What this trial is testing

Basal Bolus of Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 394
Post-approval studies (Phase 4)Study completedNCT02219750
What this trial is testing

Comparison of Premixed Insulin With Basal-plus Insulin in Type 2 Diabetes Patients

Who this might be right for
Diabetes
Mackay Memorial Hospital 181
Not applicableStudy completedNCT00699179
What this trial is testing

Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type 1 and 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 2,308
Large-scale testing (Phase 3)Study completedNCT05352815
What this trial is testing

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 1,291
Large-scale testing (Phase 3)Study completedNCT00629213
What this trial is testing

Metabolic Syndrome Risk Factor in IGT: STOP-NIDDM Trial

Who this might be right for
Metabolic Syndrome
GWT-TUD GmbH 1,429
Not applicableStudy completedNCT05514080
What this trial is testing

Evaluate Eli Lilly's Insulin Dosing Algorithm to Control Glycemia in Insulin-treated Adults With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
McGill University 10
Not applicableStudy completedNCT05111301
What this trial is testing

Control-IQ Technology in Individuals With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Treated With Insulin
Tandem Diabetes Care, Inc. 30
Post-approval studies (Phase 4)Study completedNCT00335465
What this trial is testing

Lantus Effect on Myocardial Glucose Metabolism in T2

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 15
Large-scale testing (Phase 3)Study completedNCT02749890
What this trial is testing

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Lixisenatide on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 321
Not applicableStudy completedNCT01614262
What this trial is testing

Examining The Role of CGM in T2DM

Who this might be right for
DIABETES MELLITUS, NONINSULIN-DEPENDENT, 2 (Disorder)
University of North Carolina, Chapel Hill 35
Large-scale testing (Phase 3)Study completedNCT02229383
What this trial is testing

Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
AstraZeneca 464
Post-approval studies (Phase 4)Study completedNCT05677334
What this trial is testing

Combination of Henagliflozin and Continuous Subcutaneous Insulin Infusion in T2DM

Who this might be right for
Type2diabetes
First Affiliated Hospital of Guangxi Medical University 210
Post-approval studies (Phase 4)Study completedNCT00360698
What this trial is testing

Insulin Glulisine in Type 2 Diabetic Patients

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 106
Post-approval studies (Phase 4)Study completedNCT00469092
What this trial is testing

Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 480
Large-scale testing (Phase 3)Study completedNCT00308737
What this trial is testing

Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes

Who this might be right for
Diabetes, Type 1Diabetes, Type 2
Mannkind Corporation 2,053
Post-approval studies (Phase 4)Study completedNCT00970528
What this trial is testing

Glucose Reduction by Early Acarbose Treatment in Basal Insulin

Who this might be right for
Diabetes Mellitus, Type 2
Bayer 124
Post-approval studies (Phase 4)Study completedNCT04654676
What this trial is testing

DPP4 Inhibitor on Glycemic Variability

Who this might be right for
Diabetes Mellitus, Type 2
University Malaysia Sarawak 12
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation